Antiverse Ltd and GlobalBio Inc. have extend their cancer antibody partnership to progress two PD-1 modulators to preclinial development
Tag Archive for: Antiverse
Antiverse Ltd.s AI identified eight antibodies with therapeutic potential for humans and raised €2.8m in funding for continued in-house development.